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Background. Mobility limitations are a key feature of MS and 25% will require the use of a walking aid 15 years after diagnosis.
Few studies have specifically evaluated the effectiveness of physiotherapy and exercise interventions delivered in the community
for those with significant disability.Methods. An assessor blind, block randomised, and controlled study recruited participants who
required bilateral assistance for gait and who occasionally used wheelchairs for longer distances.They were randomised to 10 weeks
of group physiotherapy (balance and strengthening exercises), individual physiotherapy, yoga group, or a control group. Results.
Repeated measures ANOVA found significant time effects for physical component of MSIS-29v2 (𝑓 = 7.993, 𝑃 = 0.006) and MFIS
(𝑓 = 8.695, 𝑃 = 0.004). The group × time interaction was significant for the BBS (𝑓 = 4.391, 𝑃 = 0.006). Post hoc analysis
revealed no difference between group and individual physiotherapy for BBS. There was no significant difference between groups
but the 6MWT improved for individual physiotherapy (𝑃 = 0.001) and MSIS-29v2 psychological score for group physiotherapy
(𝑃 = 0.005). Discussion. This study found that balance and strengthening exercises, delivered in the community to those with
significant mobility limitations, improve balance. The effect on walking endurance and patient-reported outcomes are unclear and
warrants further investigation with a larger control group with similar baseline characteristics to the intervention groups.
1. Introduction
Multiple sclerosis is a chronic progressive disease that results
in a number of symptoms including weakness, spasticity,
tremor, ataxia, sensory disturbance, and balance disruption
[1]. It is suggested that within 15–25 years of diagnosis
approximately 50% of people with MS (PwMS) will require
the use of a walking aid [2, 3]. Mobility loss is significantly
associated with loss of employment and with increasing
assistancewith activities of daily living (ADLS) [4] andPwMS
identify the continued loss of mobility as one of their greatest
concerns for their future [5]. Loss ofmobility and its resultant
impact on every day activities are reflected by the increasing
cost of care with greater disability [6].
There is an ever-expanding body of the literature to
suggest the positive effect of exercise and physiotherapy inter-
ventions. Those who use walking aids have been included
in several studies of physiotherapy interventions [7–10],
progressive resistance training (PRT) [11, 12], aerobic exercise
[13–15], and a combination of the above [16], and generally the
studies have had positive outcomes. However, as the results of
thosewho usewalking aids have not been analysed separately,
it is difficult to evaluate the effect of the interventions for
this specific population. Given the combinations and severity
of their symptoms and resulting activity limitations, it is
possible that they will respond differently to those with
minimal disability.
Few studies have specifically focused on those with
significant walking limitations that require support for gait
(EDSS 6-7). Recently Pilutti et al. [17] found that treadmill
training with body weight support resulted in significant
improvements in quality of life, with large effect sizes for
fatigue. A survey of current practice in physiotherapy [18]
found that most people with MS who use walking aids are
treated at home or in community or primary care settings.
There is therefore a need for effectiveness trials of exercise
interventions in these settings. Two studies were found that
specifically evaluated interventions at home for people with
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MS who used walking aids. A pilot study of FES cycling
at home [19] found trends for improvement in strength,
walking speed, and endurance and in thosemuscles that were
treated with electrical stimulation but the results need to be
confirmed in a larger sample. In contrast Miller et al. [20]
found no significant effect of home-based therapy, which
consisted of twice weekly physiotherapy for eight weeks.
Their small sample size may have influenced findings, which
found some increases in impact of MS and strength for the
intervention group. There is therefore a need for studies
specifically exploring the responses of people with MS who
use bilateral support for gait to interventions provided in the
community. In Ireland theMS society provides physiotherapy
and yoga interventions in community settings and commis-
sioned this study to investigate their effectiveness.
The objective of this study was to evaluate the effec-
tiveness of yoga and physiotherapy interventions delivered
in community settings for people with significant disability
due to MS who use bilateral aids for gait. The aim of this
study was to compare the effects of a ten-week programme
of group physiotherapy, individual physiotherapy, and yoga
in the community to a control group who were asked not to
change their exercise habits. Given the complex interactions
of symptoms of this group we hypothesised that individ-
ual physiotherapy intervention would have more positive
outcomes than group intervention and that physiotherapy
interventions would have a greater outcome than that due
to yoga. We also hypothesised that treatment would either
prevent deterioration or bring about improvement compared
to the control group.
2. Materials and Methods
Theprotocol for this study has been published previously [21].
This paper concerns the results for “strand B” or those people
with MS who score 3 or 4 on the mobility section of the Guys
Neurological Disability Rating Scale [22]. This indicates that
they use bilateral assistance for gait andmay use a wheelchair
for longer distances.The study received ethical approval from
the relevant committees in the 10 regions where the study
took place.The trial registration number is ISRCTN77610415.
2.1. Participants. People who had their MS diagnosis con-
firmed by a consultant physician were included in the study.
People with MS were excluded from the study if they had
experienced an exacerbation of symptoms due to relapse or
initiated steroid treatment in the last 12 weeks, were pregnant
at the time of referral, or were under 18 years of age.
2.2. Procedure and Randomisation. Referral was made to the
regional offices ofMS Ireland by the persons themselves, their
physiotherapist, general practitioner, consultant, or nurse.
Participants were screened for eligibility, sent the relevant
information leaflet, and gave informed consent.Once consent
for 8 people in that geographical region was obtained, they
were block randomised to one of the three interventions or to
the control group by the national coordinator in MS Ireland.
The randomisation sequence was generated by removing
strips of paper from an envelope and was concealed from
all involved in the study until the point of randomisation
of that group. It should be noted that a number of blocks
of participants were not treated as randomised. Groups
allocated to yoga and to the control group lobbied to receive
physiotherapy and were subsequently randomised to either
group or individual physiotherapy.
2.3. Assessments. Assessments were carried out at baseline
(week 1) and postintervention (week 12) by a blinded assessor.
The following outcome measures were used: Berg Balance
Scale (BBS) six-minute walk test (6MWT), Multiple Sclerosis
Impact Scale 29 version 2 (MSIS), and Modified Fatigue
Impact Scale (MFIS).
The BBS is a clinical scale that evaluates balance in sitting
and standing and rates performance from 0 (cannot perform)
to 4 (normal performance). The BBS was found to have a
good concurrent validity and a cut-off score of 44 (out of
56) was established as a criterion to identify PwMS who have
high risk of falls [23]. It was found to have high test-retest
and interrater reliability, both having intraclass correlation
coefficients (ICCs) of 0.96 [23].
In the 6MWT, the participants were asked to walk for a
period of six minutes and the distance walked was recorded.
Paltamaa et al. [24] found that the 6MWT is highly reliable in
people with mild-to-moderate MS (EDSS 2–6.5) and Marrie
and Goldman [25] validated the 6MWT as an outcome
measure for PwMS. Subjects were instructed to walk “as
quickly and safely as possible” as recommended by Fry and
Pfalzer [26].
The MSIS-29v2 is a patient-reported outcome measure
that assesses the physical and psychological impact of MS.
It consists of 29 questions and is scored from 0 to 100
with higher scores indicating a greater impact of MS. It
was developed and evaluated using robust psychometric
techniques and is valid, reliable, and sensitive to change in
PwMS [27–29].
The MFIS is a structured self-report questionnaire. It
consists of 20 questions and is scored from 0–84. A higher
score indicates a greater impact of fatigue.TheMFIS has good
reproducibility in an international sample of people with MS
[30]. A cutoff of 38 points indicates clinically relevant fatigue
[31].
2.4. Interventions. All interventions took place for an hour
a week, for 10 weeks. The physiotherapy group intervention
was a self-paced circuit style class of exercises that targeted
strength and balance with the aim of increasing balance
and mobility. The exercises were adapted from the falls
prevention literature where similar programmes have been
seen to improve, balance, and reduce the number of falls in
an elderly population [32] and in people with MS [11].
The six exercises and possible progressions are described
in Table 1. These were performed in sets of 12 at a self-paced
rate. When a participant was able to perform 12 repetitions
of an exercise safely, it was progressed up to 3 sets of 12 rep-
etitions. The progression was dependent on the ability of the
participant and their safety while performing the exercises.
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Table 1: Group physiotherapy exercises and their progressions.
Sit to stand Squat Heel raises
Hand positioning—participants may
initially need to use hands for support to
rise from chair, then progressing to hands
by side and then to hands across chest.
Seat height—participants may initially
require a higher seat height which can be
lowered to increase the intensity of the
exercise.
Repetitions—to be performed in sets of
12 and number of sets to be increased to 3
as participant progresses.
Weights—handheld weights may be given
to participants who need further
progression.
Support—participants may initially need
bilateral support; this can be decreased to
unilateral and then to no support as
participants’ ability increases.
Weights may be given to participants who
are able to perform 3 sets of 12 squats
safely with no support.
Support—participants may initially need
bilateral support; this can be decreased to
unilateral support and then to
independent calf raises as participant
progresses.
Repetitions—to be performed in sets of
12, to be increased as participant
progresses.
Other options—if participants are able,
they may perform single leg calf raises, or
if they can perform 3 sets of 12
independent calf raises, weights can be
added as further progression.
Step ups Side stepping Tandem
Support—participants may begin with
bilateral support and then decrease to
unilateral support, then to no support.
Stepping—initially participants may step
onto step and back to starting position,
then step onto step and over, and then
onto step , over, and backwards to
starting position.
Step height—when participants are
comfortable with all directions of
stepping, step height may be increased.
Support—participants may begin with
bilateral support, then decrease to
unilateral support, and then to no
support.
Number of steps—initially participants
may only take one step in each direction.
This can be increased as participants’
ability increases. If a participant is unable
to take a step to the side, weight shifting
from side to side in standing may be
performed and progressed to stepping
when the participant is able.
Support—participants may begin bilateral
support, then decrease to unilateral
support, and then to no support.
Stepping—participants may initially just
place one foot in front of the other and
hold this position. The number of steps
can then be increased as the participant
progresses.
Crossover—participants may become
competent at tandem walking. This can
then be progressed to one foot crossing
over in front of the other.
The participants allocated to individual physiotherapy
received individual treatment depending on the problem
list and goals established by the Chartered Physiotherapist
who was treating them. The content of the intervention was
recorded for each individual treatment session. The duration
of the individual sessions was the same as the group led
physiotherapy.
Participants attended a weekly yoga class of approxi-
mately one-hour duration. All yoga instructors were mem-
bers of The Yoga Federation of Ireland and kept a log of the
content of each yoga class.
2.5. Analysis. All data was analysed using Predictive Analytic
Software (PASW) Statistics 17. The distribution of the data
was analysed for normality using Histograms, Quantile-
Quantile plots, and the ShapiroWilk statistic. Baseline differ-
ences between groups were assessed using one-way ANOVA
(normally distributed data), Kruskal Wallis (nonnormally
distributed data), and Chi square test for independence
(categorical data).
Repeated measures ANOVAwas performed for the phys-
ical component of theMSIS-29v2, theMFIS, and the BBS due
to the normal distribution of the data. Bonferroni corrections
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Assessed for eligibility
n = (161)
Excluded (n = 15)
did not meet selection criteria
Randomized (n = 146)
Lost to followup at week 12
(n = 10)
Relapse (n = 2)
Unwell on the day (n = 1)
Inclement weather (n = 1)
On holidays (n = 2)
Moved to strand C (n = 3)
Unknown (n = 1)
Analysed (n = 35)
Allocated to group physiotherapy
(n = 66)
Allocated to control
(n = 19)
Lost to followup at week 12
(n = 18)
Relapse (n = 1)
Unwell on the day (n = 5)
Steroids for low back pain (n = 1)
Fall (n = 1)
Moved to Strand C (n = 2)
On holidays (n = 1)
Unknown (n = 3)
Analysed (n = 48)
Lost to follow up at week 12
(n = 4)
Relapse (n = 2)
Rapidly progressing MS (n = 1)
Assessment clashed with hospital
appointment (n = 1)
Analysed (n = 15)
Allocated to yoga
(n = 16)
Lost to followup at week 12
(n = 3)
Unknown (n = 2)
Analysed (n = 13)
Unwell and discontinued
intervention (n = 3)
Requested 1 : 1 treatment (n = 1)
Allocated to 1 : 1 physiotherapy
(n = 45)
Discontinued intervention
by choice (n = 1)
Figure 1: Flow of participants through the trial.
were made and the 𝑃 values were adjusted accordingly
by PASW. Post hoc analysis was conducted using paired-
samples 𝑡-tests for within-group changes and independent
𝑡-tests on the change scores for between-group differences.
For the psychological component of the MSIS-29v2 and the
6MWT the normality tests yielded 𝑃 values of < 0.05 and the
histograms revealed skewed data; therefore, the assumptions
of parametric testing were not met. Wilcoxon Signed Rank
Tests were used to analyse the differences within groups and
the Kruskal Wallis and Mann Whitney 𝑈 tests were used to
analyse the differences in change scores between groups.
3. Results
The flow of participants through the trial is illustrated in
Figure 1. At baseline the control group were significantly
younger and had a significantly shorter time since diagnosis.
Also the yoga group had significantly less impact of fatigue
(Table 2). The overall attrition rate for the study was 22.32%.
The reasons for attrition and the rate of dropouts were similar
across the groups (Figure 1).
The median number of sessions attended was 8 (semi-
interquartile range 1.5), 9 (1), and 8 (2.25), for group
physiotherapy individual physiotherapy and yoga, respec-
tively. There was no significant difference between the three
intervention groups for the number of sessions attended,
𝑃 = 0.139 using the Kruskal-Wallis test. Analysis of the
documentation of the content of the interventions revealed
that group physiotherapy was performed as prescribed.
For individual physiotherapy, three out of the four phys-
iotherapists delivered strength and balance exercises that
were similar to those prescribed for the group physiotherapy
in addition to other treatments specific to the individuals’
problems. Additional components included pacing tech-
niques, specific lower back exercises, walking, stretching,
and bridging exercises. There were three yoga led groups.
Relaxation, meditation, breathing techniques, and stretching
were common to all three classes. One of the three classes
included squatting, which was one of the prescribed exercises
for the group physiotherapy intervention. Other components
that made up the yoga classes included maintaining different
static poses, for example, themountain pose, the cat pose and
the tailor pose (2 classes), and self-massage (1 class).
The descriptive statistics and post hoc tests for all out-
come measures are presented in Table 3. Repeated Measures
ANOVA showed a significant time effect for the physical
component of the MSIS-29v2 (𝑓 = 7.993, 𝑃 = 0.006) and the
MFIS (𝑓 = 8.695, 𝑃 = 0.004). The group × time interaction
was significant for the BBS (𝑓 = 4.391, 𝑃 = 0.006). All
interventions showed a statistically significant improvement
fromWeek 1 toWeek 12 on theBBSwhichwas greater than the
control group. Post hoc analysis using an Independent 𝑡-test
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Table 2: Baseline comparisons between groups.
Group physiotherapy
𝑛 = 48
Individual physiotherapy
𝑛 = 35
Yoga
𝑛 = 13
Control
𝑛 = 15
𝑃 value
Age in years (SIQR) 57 (10) 52 (11) 58 (8) 49 (6) 0.029b
Gender
Male/female (𝑛) 18/30 15/20 5/8 2/13 0.247c
GNDS mobility section score
3 (%) 28 (58) 21 (60) 9 (69) 5 (33.3) 0.256c
4 (%) 17 (35) 13 (37) 4 (30) 10 (66.7)
Type of MS
RRMS (𝑛) 13 7 4 5
0.152cSPMS (𝑛) 20 16 5 5
PPMS (𝑛) 8 11 2 5
Unknown (𝑛) 7 1 2 0
Time since diagnosis (years) 18 (9) 13 (8) 15 (8) 10 (3) 0.002a
Time since onset of symptoms (years) 22 (11) 20 (13) 21 (14) 15 (7) 0.233a
MSIS-29v2 physical component 50.5 (±9) 53.9 (±11.3) 48 (±10) 55 (±9) 0.107a
MSIS-29v2 psychological component 18 (5.5) 18 (5) 15 (3) 16.5 (3.25) 0.293
MFIS 40.7 (±16) 46.7 (±14) 30.4 (±17) 47 (±15) 0.034a
BBS 28.5 (±9) 30 (±11.5) 22 (±13) 18 (±6) 0.391a
6MWT (m) 105.5 (56) 89 (63) 66 (57) 79 (49) 0.103a
SIQR: semi-interquartile range, GNDS: Guys Neurological Disability Scale, RR: relapsing remitting, SP: secondary progressive, PP: primary progressive, MSIS:
multiple sclerosis impact scale, MFIS: modified fatigue impact scale, BBS: berg balance scale, 6MWT: six-minute walk test, a = one way ANOVA, b = Kruskal
Wallis test, c = Chi Squared test.
revealed there was no significant difference between Group
and one to one physiotherapy on the BBS (𝑃 = 0.242). Due to
the small numbers in the yoga group, post hoc comparisons
to the physiotherapy groups were not conducted.
Nonparametric analysis revealed a significant change
over time on the 6MWT for one-to-one physiotherapy (𝑃 =
0.001) and on the MSIS-29v2 psychological component for
group physiotherapy (𝑃 = 0.005). The Kruskal Wallis test
showed that there was no statistically significant difference
between groups for the psychological component of the
MSIS-29v2 or the 6MWT.
The control group showed a similar magnitude of change
to the physiotherapy intervention groups on the self-report
outcome measures.
The main problems reported by the participants are
presented in Figure 2. Mobility, fatigue, and balance were the
most commonly reported main problem.
4. Discussion
This is only one of a few trials that specifically address the
effects of interventions in the community for those with
significant mobility limitations who use bilateral support
for gait. These data provide preliminary evidence of the
effectiveness on balance of group and individual physio-
therapy interventions delivered pragmatically in community
settings.
The only evidence to support our hypotheses that treat-
ment improves outcomes is from the BBS results. All three
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Figure 2: Main problems reported by participants.
intervention groups improved significantly while the scores
of the control groups worsened. The worsening of scores in
the control group is not unexpected in this groupwho present
primarily with progressive MS. The magnitude of the mean
improvements in our studywas similar to those of Cattaneo et
al. [7] who found an improvement of 4.6 as a result of balance
exercises based on motor strategies. However, this degree of
change is less than the 6.5 value for the minimal detectable
change for people with MS [33]. It should be noted, however,
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Table 3: Descriptive statistics for study outcome measures.
Group physiotherapy
𝑛 = 48
Individual physiotherapy
𝑛 = 36
Yoga
𝑛 = 13
Control
𝑛 = 15
MSIS-29v2 physical component
Premean (SD) 50.5 (9.5) 54 (11.5) 48.3 (10.5) 55.3(9.5)
Postmean (SD) 45.9 (10.5) 49.4 (12) 49.6 (11.6) 50.5 (11.3)
Mean Difference −4.54 −4.52 1.3 −4.8
(95% CI) (−7.5, −1.5) (−7.9, −1.1) (−4.7, 7.3) (−10.4, −0.6)
𝑃 value (within group)a 0.004∗ 0.012∗ 0.645 0.08
MSIS-29v2 psychological component
Premedian (SIQR) 18 (5.5) 18 (5.38) 14 (2.2) 17 (4)
Postmedian (SIQR) 15 (5.7) 17 (4.8) 15 (4) 15 (4.5)
Median difference −3 −1 1 2
𝑃 value (within group)b 0.005∗ 0.057 0.281 0.507
MFIS (total score)
Premean (SD) 40.7 (16.2) 46.6 (14.8) 30.4 (17.1) 49 (15.5)
Postmean (SD) 35.6 (15.6) 39.5 (13.7) 32.5 (19.5) 42.6 (17.1)
Mean difference −5.1 −7.4 2.15 −6.4
(95% CI) ( −9.1, −1.2) (−11.6, −3.2) (−2.9, 7.2) (−13.1, 0.4)
𝑃 value (within group)a 0.011∗ 0.001∗ 0.374 0.062
BBS
Premean (SD) 28.8 (9.5) 30.4 (11.6) 22.6 (12.6) 24.9 (11.6)
Postmean (SD) 34.5 (9.8) 34.2 (9.8) 27.9 (11.5) 21.8 (11.9)
Mean difference 5.7 3.7 5.3 −3.1
(95% CI) (−3.6, 7.8) (−1, 6.3) (−3.1, 7.5) (−2.8, 9.0)
𝑃 value (within group)a <0.0001∗ 0.008∗ <0.0001∗ 0.258
6-minute walk test (m)
Premedian (SIQR) 101 (39.5) 83.8 (39.8) 70 (30) 83.5 (44)
Postmedian (SIQR) 121.2 (47.4) 100 (55) 45 (54.5) 90 (35)
Median difference 20.2 16.2 −25 6.5
𝑃 value (within group)b 0.08 0.002∗ 0.553 0.363
SD: standard deviation, SIQR: semi-interquartile range, MSIS: multiple sclerosis impact scale, MFIS: modified fatigue impact scale, BBS: berg balance scale,
∗statistically significant at 𝛼 = 0.05, apaired samples 𝑡-test, bWilcoxon signed rank test.
that our participants started with far lower BBS scores (22–
30) than those evaluated in previous studies (>40); therefore,
this degree of change may be clinically relevant to this degree
of balance deficit. Interestingly this improvement in balance
does translate to a reduction in both falls risk and number of
falls [34]. Because of the small sample sizes confirmation of
the effect of yoga is required and the effect of physiotherapy
interventions needs further comparison to a larger, matched,
and control group.
We hypothesised that individual physiotherapy would
be more effective than the group interventions. While indi-
vidual physiotherapy was tailored to the individual goals
and impairments of the participants, the group intervention
aimed to improve balance andmobility and was tailored only
to ability level for those exercises. Post hoc analysis of the
individual and group physiotherapy treatments suggests that
there were no differences on the BBS between groups. As
this trial was not planned as a noninferiority study, further
comparison of group and individual physiotherapy for this
population is warranted using a range of outcomes.
The main problem reported by the participants was
walking/mobility limitations. The percentage improvements
in 6MWT were 20.1% for group and 19.4% for individual
physiotherapy, while the yoga group worsened by 35%.
The high variability in the 6MWT data at baseline and in
response to treatmentmay have led to nonsignificant findings
despite relatively large median and % changes. The lack of
deterioration in the control group is conflicting with the BBS
data and suggests that further evaluation of this measure with
larger groups with similar baseline characteristics is required.
There is conflicting evidence around the efficacy of yoga
for mobility outcomes in PwMS in people with minimal
gait impairment. Ahmadi et al. [35] evaluated the effect of
yoga in those with less gait limitations and found small but
statistically significant effects on 2MWT and 10MWT. The
other strand of this study (those who use at most a stick
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to walk) did not have statistically significant improvements
in 6MWT following yoga [36]. The lack of improvement in
walking endurance in both arms of this study may reflect the
specificity principles of exercise; they practiced static poses
and not the specific elements and task of walking.
The finding that participants randomised to the yoga and
control groups lobbied to receive immediate physiotherapy
interventions suggests that this cohort perceive a need or
preference for physiotherapy. Hence, these data provide some
new information about the treatment preferences of those
people with MS who require bilateral support for gait.
Patient preference may have contributed to the deterio-
ration in self-reported measures in the yoga group, which
conflicts with the objective measure of balance. A review of
studies that used a randomised preference design [37] found
that patients who received their preference had significantly
greater improvements. Additionally, authors have suggested a
“resentful demoralisation” [38] when patients do not receive
their preferred treatment and this may explain the deteriora-
tion in the self-reported measures in the yoga group.
4.1. Limitations. There are a number of methodological lim-
itations in this study. Selection bias arose as several groups
were not treated as randomised. This resulted in detection
bias as the groupswere not similar at baseline. At baseline, the
control group were significantly younger and had a shorter
time since diagnosis. However, they were similar for all
clinical measures with the exception of theMFIS score for the
yoga group.The score of 30.4 on theMFIS for the yoga group
is lower than the cutoff of 38 for clinically meaningful fatigue
and may indicate that they were not significantly fatigued to
start with.
An additional element of detection bias is present as it
was not possible to “blind” the participants to their group
allocation. This is not unique to this study and remains a
challenge in rehabilitation research.
The contact with an assessor on two occasions may
also have led to elements of performance bias. While not
statistically significant the control group improved on the
self-reported outcomemeasures to the samemagnitude as the
treatment groups.This suggests that there may be a “placebo”
effect of contact on the impact of MS and impact of fatigue.
The dropout rate across the study was 22% and con-
tributes to attrition bias. Completer analysis is presented as it
is inappropriate to impute values for intention to treat analysis
when more than 20% of the data is missing [39]. Given the
variable nature of the disease it was also felt that other forms
of intention to treat analysis were not appropriate as the
rate of deterioration or improvement between participants is
variable and unpredictable.
5. Conclusions
These data provide preliminary evidence that 10-week inter-
ventions consisting of balance and strengthening exercises
improve balance; however, given the methodological limi-
tations of the trial, confirmation of these findings with a
larger, matched control group is required. Post hoc analysis
of the data suggests that the response to group and individual
physiotherapy for balance is similar but this also requires
confirmation in a trial that aims to compare this effect
directly. People with MS who use bilateral support for gait
indicated their preference for physiotherapy interventions
over waiting three months for treatment or participating in
yoga. Patient preference and the placebo effect of contact may
have influenced the patient-reported outcome measures.
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